| 臺大學術典藏 |
2020-04-28T07:25:12Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
CHIH-HUNG HSU; Yeh K.-H.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Guo J.-C.; Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Yeh K.-H.;Chih-Hung Hsu;Lee J.-M.; Lee J.-M. |
| 臺大學術典藏 |
2020-04-28T07:25:08Z |
Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives
|
Kuo H.-Y.;Guo J.-C.;Chih-Hung Hsu; Kuo H.-Y.; Guo J.-C.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2020-04-27T08:45:07Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Chia-Hsien Cheng;Yeh K.-H.;Hsu C.-H.;Lee J.-M.; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; CHIA-HSIEN CHENG; Yeh K.-H.; Hsu C.-H.; Lee J.-M. |
| 臺大學術典藏 |
2020-04-10T12:51:03Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang S.-H.;Kuo T.-C.;Wu H.;Guo J.-C.;Chiun Hsu;Hsu C.-H.;Tien Y.-W.;Yeh K.-H.;Cheng A.-L.;Kuo S.-H.; Yang S.-H.; Kuo T.-C.; Wu H.; Guo J.-C.; Chiun Hsu; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2020-04-10T12:50:58Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
Yang S.-H.;Guo J.-C.;Chiun Hsu;Kuo S.-H.;Tien Y.-W.;Cheng A.-L.;Yeh K.-H.; Yang S.-H.; Guo J.-C.; Chiun Hsu; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.; Yen C.-J.; Chao Y.; Lu L.-C.; Hsu C.; YU-YUN SHAO; Lu L.-C.;Hsu C.;Yu-Yun Shao;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.;Lin C.-C.;Lin C.-Y.;Hsieh M.-S.;Kuo H.-Y.;Lien M.-Y.;Yu-Yun Shao;Huang T.-C.;Hsu C.-H.; Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; YU-YUN SHAO; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2020-03-31T03:59:24Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Yeh K.-H.; Cheng A.-L.; Wang H.-P.; Cheng J.C.-H.; Hsu F.-M.; JANG-MING LEE; Huang P.-M.; Chang C.-H.; Lin C.-C.; Hsieh M.-S.; Guo J.-C.; Huang T.-C. |
| 臺大學術典藏 |
2020-03-31T03:59:16Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Yeh K.-H.;Hsu C.-H.;Jang-Ming Lee; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; JANG-MING LEE |
| 臺大學術典藏 |
2020-03-05T08:04:00Z |
Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma
|
Yang P.-C.;Guo J.-C.;Min-Shu Hsieh;Lin C.-C.;Hsu C.-H.; Yang P.-C.; Guo J.-C.; MIN-SHU HSIEH; Lin C.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:56Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Hsu C.-H.; Huang T.-C.; Shao Y.-Y.; Lien M.-Y.; Kuo H.-Y.; MIN-SHU HSIEH; Lin C.-Y.; Lin C.-C.; Guo J.-C.; Guo J.-C.;Lin C.-C.;Lin C.-Y.;Min-Shu Hsieh;Kuo H.-Y.;Lien M.-Y.;Shao Y.-Y.;Huang T.-C.;Hsu C.-H. |
| 臺大學術典藏 |
2020-03-05T06:28:31Z |
Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis
|
Guo J.-C.;Chang C.-C.;Yang C.-Y.;Liao B.-C.;Jau-Yu Liau;Chang C.-H.;Yeh K.-H.; Guo J.-C.; Chang C.-C.; Yang C.-Y.; Liao B.-C.; JAU-YU LIAU; Chang C.-H.; Yeh K.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:07Z |
Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer
|
Yeh K.-H.; YU-WEN TIEN; Cheng A.-L.; Kuo S.-H.; Yang S.-H.; Guo J.-C.; Yang S.-H.;Guo J.-C.;Yeh K.-H.;Yu-Wen Tien;Cheng A.-L.;Kuo S.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:07Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Cheng A.-L.; Kuo S.-H.; Yeh K.-H.; YU-WEN TIEN; Hsu C.-H.; Hsu C.; Guo J.-C.; Wu H.; Kuo T.-C.; Yang S.-H.; Yang S.-H.;Kuo T.-C.;Wu H.;Guo J.-C.;Hsu C.;Hsu C.-H.;Yu-Wen Tien;Yeh K.-H.;Cheng A.-L.;Kuo S.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:07Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; YU-WEN TIEN; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:01Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
Kuo S.-H.; YU-WEN TIEN; Cheng A.-L.; Yeh K.-H.; Hsu C.; Guo J.-C.; Yang S.-H.; Yang S.-H.;Guo J.-C.;Hsu C.;Kuo S.-H.;Yu-Wen Tien;Cheng A.-L.;Yeh K.-H. |
| 國立成功大學 |
2020 |
Fin-gated nanochannel array gate-recessed AlGaN/GaN metal-oxide-semiconductor high-electron-mobility transistors
|
Lee, C.-T.;Guo, J.-C. |
| 臺大學術典藏 |
2019 |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C; Chia-Chi Lin; Lin C.-Y; Hsieh M.-S; Kuo H.-Y; Lien M.-Y; Shao Y.-Y; Huang T.-C; Hsu C.-H. |
| 臺大學術典藏 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 國立成功大學 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu, Lu L.-C.;Hsu, C.;Shao, Y.-Y.;Chao, Y.;Yen, C.-J.;Shih, I.-L.;Hung, Y.-P.;Chang, Chang C.-J.;Shen, Y.-C.;Guo, J.-C.;Liu, T.-H.;Hsu, C.-H.;Cheng, A.-L. |
| 臺大學術典藏 |
2018-09-10T18:05:09Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang, S.-H.;Lee, J.-C.;Guo, J.-C.;Kuo, S.-H.;Tien, Y.-W.;Kuo, T.-C.;Cheng, A.-L.;Yeh, K.-H.; TING-CHUN KUO; YU-WEN TIEN; JEN-CHIEH LEE; ANN-LII CHENG |
| 臺大學術典藏 |
2017 |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Guo J.-C.; JEN-CHIEH LEE; Yang S.-H.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2017 |
Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis
|
CHIN-CHEN CHANG; Yang C.-Y.; Liao B.-C.; Liau J.-Y.; Chang C.-H.; Yeh K.-H.; Guo J.-C.; Guo J.-C.;Chin-Chen Chang;Yang C.-Y.;Liao B.-C.;Liau J.-Y.;Chang C.-H.;Yeh K.-H. |
| 臺大學術典藏 |
2017 |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yeh K.-H.; Cheng A.-L.; Kuo T.-C.; Tien Y.-W.; Kuo S.-H.; JEN-CHIEH LEE; Guo J.-C.; Yang S.-H.; Yang S.-H.;Jen-Chieh Lee;Guo J.-C.;Kuo S.-H.;Tien Y.-W.;Kuo T.-C.;Cheng A.-L.;Yeh K.-H. |
| 臺大學術典藏 |
2016 |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
CHIH-HUNG HSU; Hsu C.; Guo J.-C.; Wu H.; Yang S.-H.;Kuo T.-C.;Wu H.;Guo J.-C.;Hsu C.;Chih-Hung Hsu;Tien Y.-W.;Yeh K.-H.;Cheng A.-L.;Kuo S.-H.; Yang S.-H.; Kuo T.-C.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
